Thomas Demelfi

Thomas DeMelfi currently serves as Vice President of Regulatory Affairs and Quality at Neuron23 since August 2024. Previously, Thomas held roles as Vice President and Executive Director of Regulatory Affairs at Aadi Bioscience, Inc. from September 2020 to August 2024, and served as Executive Director of Regulatory Affairs at Ionis Pharmaceuticals, Inc. from September 2019 to September 2020. Thomas's earlier experience includes positions as Senior Director and Director of Regulatory Affairs at Atara Biotherapeutics, as well as roles in regulatory affairs and corporate development at Amgen. Thomas began a career in research with roles at GlaxoSmithKline, the University of Pennsylvania, and Thomas Jefferson University. Educational qualifications include a Master of Science in Microbiology from Jefferson Health and a Bachelor of Science in Biology and Microbiology from Bloomsburg University of Pennsylvania.